Literature DB >> 27816927

Use of testicular sperm for ICSI in oligozoospermic couples: how far should we go?

Armand Zini1, Phil V Bach2, Ahmad H Al-Malki3, Peter N Schlegel2.   

Abstract

In 1992 and subsequently, several reports indicated that ICSI was a successful technique to achieve clinical pregnancy and live birth using spermatozoa with severely impaired characteristics. The initial optimism over the ability of ICSI to overcome significant sperm abnormalities was later tempered by the findings of more recent publications suggesting that some sperm deficits may not be as effectively treated with ICSI. In search for effective treatment for couples with severe male factor, a number of small retrospective and prospective studies have reported high pregnancy and live birth rates using testicular sperm for men with necrozoospermia, cryptozoospermia and oligozoospermia with or without elevated sperm DNA damage. Although the data suggest that there may be some benefit in performing testicular sperm retrieval (TSR)-ICSI in select groups of non-azoospermic infertile men, there are potential risks involved with TSR. Clinicians should balance these risks prior to the recommendation of TSR-ICSI on the result of a semen analysis or sperm DNA test alone. Careful evaluation and management of male factor infertility is important. The use of TSR-ICSI in the absence of specific sperm DNA defects is still experimental.
© The Author 2016. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  ICSI; male infertility; sperm DNA; sperm retrieval; testicular sperm

Mesh:

Year:  2016        PMID: 27816927     DOI: 10.1093/humrep/dew276

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  14 in total

1.  Switching to testicular sperm after a previous ICSI failure with ejaculated sperm significantly improves blastocyst quality without increasing aneuploidy risk.

Authors:  Irene Hervas; Maria Gil Julia; Rocío Rivera-Egea; Ana Navarro-Gomezlechon; Laura Mossetti; Nicolás Garrido
Journal:  J Assist Reprod Genet       Date:  2022-08-16       Impact factor: 3.357

Review 2.  Protein biomarkers for male artificial insemination subfertility in bovine spermatozoa.

Authors:  Hiroshi Harayama; Kenta Minami; Kazumi Kishida; Taichi Noda
Journal:  Reprod Med Biol       Date:  2017-03-20

3.  A Strengths-Weaknesses-Opportunities-Threats (SWOT) analysis on the clinical utility of sperm DNA fragmentation testing in specific male infertility scenarios.

Authors:  Sandro C Esteves; Ashok Agarwal; Chak-Lam Cho; Ahmad Majzoub
Journal:  Transl Androl Urol       Date:  2017-09

4.  Clinical utility of sperm DNA fragmentation testing: article overview: Practice Recommendations of Sperm DNA Fragmentation Testing: Expert Commentaries by Invited Authors and Replies by Guest Editors Contributors from Europe.

Authors:  Jaime Gosálvez
Journal:  Transl Androl Urol       Date:  2017-09

5.  Sperm DNA damage diagnostics: when and why.

Authors:  Rima Dada
Journal:  Transl Androl Urol       Date:  2017-09

6.  Using sperm testing to improve patient and offspring health: rational, evidence-based care of the infertile male in the ART clinic.

Authors:  Douglas T Carrell; James Hotaling
Journal:  Transl Androl Urol       Date:  2017-09

Review 7.  Coffee and caffeine intake and male infertility: a systematic review.

Authors:  Elena Ricci; Paola Viganò; Sonia Cipriani; Edgardo Somigliana; Francesca Chiaffarino; Alessandro Bulfoni; Fabio Parazzini
Journal:  Nutr J       Date:  2017-06-24       Impact factor: 3.271

8.  MAT, a Novel Polyherbal Aphrodisiac Formulation, Enhances Sexual Function and Nrf2/HO-1 Pathway While Reducing Oxidative Damage in Male Rats.

Authors:  Kazim Sahin; Mehmet Tuzcu; Cemal Orhan; Hasan Gencoglu; Nurhan Sahin; Fatih Akdemir; Gaffari Turk; Ismet Yilmaz; Vijaya Juturu
Journal:  Evid Based Complement Alternat Med       Date:  2018-04-29       Impact factor: 2.629

9.  Commentary on sperm DNA fragmentation testing clinical guideline.

Authors:  Rodolfo A Rey
Journal:  Transl Androl Urol       Date:  2017-09

10.  Further evidence supports the clinical utility of sperm DNA fragmentation testing in male infertility workup and assisted reproductive technology.

Authors:  Sandro C Esteves; Ahmad Majzoub; Ashok Agarwal
Journal:  Transl Androl Urol       Date:  2017-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.